KL1333

CAS No. 1800405-30-4

KL1333( NQO1 activator 1 )

Catalog No. M23811 CAS No. 1800405-30-4

KL1333 enhances energy metabolism and mitochondrial dysfunction in MELAS fibroblasts.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 177 In Stock
5MG 259 In Stock
10MG 404 In Stock
25MG 665 In Stock
50MG 888 In Stock
100MG 1251 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KL1333
  • Note
    Research use only, not for human use.
  • Brief Description
    KL1333 enhances energy metabolism and mitochondrial dysfunction in MELAS fibroblasts.
  • Description
    KL1333 enhances energy metabolism and mitochondrial dysfunction in MELAS fibroblasts. Elevated NAD+ levels trigger the activation of SIRT1 and AMPK, and subsequently activates PGC-1α. NQO1 activator 1 is an orally available NAD+ modulator. It reacts with NAD(P)H: NQO1 as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NQO1 activator 1
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NADPH
  • Recptor
    NQO1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1800405-30-4
  • Formula Weight
    240.26
  • Molecular Formula
    C14H12N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:245 mg/mL (1019.73 mM; Need ultrasonic)
  • SMILES
    CC(C)c1nc(-c(cccc2)c2C(C2=O)=O)c2[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Seo KS, et al. KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts. Front Neurol. 2018 Jul 5;9:552.
molnova catalog
related products
  • KL1333

    KL1333 enhances energy metabolism and mitochondrial dysfunction in MELAS fibroblasts.

  • gp91 ds-tat

    gp91 ds-tat is a NADPH oxidase (NOX2) inhibitor that reduces NOX2 expression.

  • NoxA1ds

    Potent and selective NADPH oxidase 1 (NOX1) inhibitor (IC50 = 20 nM). Exhibits selectivity for NOX1 over NOX2, NOX4, NOX5 and xanthine oxidase. Inhibits NOX1-derived O2- production in HT-29 human colon cancer cells. Attenuates VEGF-induced human pulmonary artery endothelial cell migration under hypoxic conditions in vitro. Cell permeable.